What is Your
Cannabis Investment Strategy?
We help family offices, accredited investors, RIAs and institutions achieve their investment and impact goals.
Careful Curators of Opportunity
MAZAKALI leadership has been strategically investing in cannabis since 2014. Today, we offer clients a rare blend of know-who, know-what and know-how through the MAZAKALI Outsourced Cannabis Investment Officer (OCIO) service. Sustainable, scalable and sensible investment opportunities are carefully selected with goals of both profit and a difference.
The MAZAKALI Advantage
We build customized Cannabis Investment Portfolios (CIPs) for family offices, accredited investors, RIAs and institutions who believe–as we do–that purposeful investment in cannabis can benefit our planet, people, and plants in addition to profits. Our clients are just as passionate about doing good as they are about doing well. See how we partner:
Years of intimate conversations with industry pioneers fuel our knowledge and foster our relationships. Our connections create opportunity. Our conversations fuel innovation. We welcome purposeful investors to join us on this journey.
GreenPapers®. Public cannabis equity fell in excess of 50% in 2018 and has lost another 35% this year, with the peak-to-trough decline exceeding 75% on an index basis. Going public has traditionally offered significant advantages to companies<…> Dec 2019.
As featured in Benzinga.
An engaging discussion on cannabis investment including:
- Cannabis as an emerging market;
- Comparisons to the technology boom;
- 32K private cos vs. the 350 public cos the news cycle focuses on;
- Fundamentals as an imperative for survival;
- Cannabis as likely the best performing asset class over the next decade. Oct. 2019
GREENPAPERS®. The cannabis industry has been compared to alcohol, gambling, Chinese herbal medicine and the dot-com boom. While there are parallels one can draw to each of these industries, it is useful to view the industry through an emerging market lens. Oct. 2019
In this interview MAZAKALI CEO Sumit Mehta reflects on the cannabis industry, “It’s not an industry it’s a movement. Anyone with a vertebrae can benefit from this plant.” During this 18 minute interview with Green Flower CEO Max Simon Sumit shares how hemp and non-hemp cannabis will impact our future food, fuel, fiber, pharmaceuticals and much more.
MAZAKALI Founder and CEO Sumit Mehta is the Finance and Strategy consultant to The Arcview Group, the largest private cannabis investor network in the United States. We are pleased to offer $100 off with code MAZAKALI100 to this authoritative source of data and insights into the legal cannabis industry. Click here for report executive summary.
Authority Through Knowledge
What is Hemp?
Hemp is cannabis and cannabis is hemp.
Differences are defined by history and use, by legality and by botany.
History & Use: Hemp has traditionally been used to describe plants grown for industrial use, plants that won’t get you ‘high’ but can be used to make clothing, rope and sails.
Legality: If a cannabis plant has THC content below 0.3%, it is considered hemp and therefore completely legal. This definition is socially constructed rather than being scientifically accurate.
Botany: Botanically speaking, there is more debate than there are conclusions on what is hemp vs. non-hemp cannabis.
So while there is plenty of debate around what is hemp and what is non-hemp cannabis, differences.are defined more by history and use than by genetics and botany.
What is Non-Hemp Cannabis?
Non-hemp cannabis has traditionally been called marijuana.
Differences from hemp are defined by history and use, by legality and by botany.
History & Use: Historically, the term marijuana originated in Mexico and has been used to describe what many also call pot or weed and has traditionally been smoked or eaten to get ‘high’.
Legality: If a cannabis plant has THC content greater than 0.3%, it is considered marijuana or non-hemp cannabis and is illegal in the U.S.. When the U.S. government decided on 0.3% as the dividing line between hemp and marijuana, even they admitted that it was arbitrary.
Botany: Botanically speaking, there is more debate than there are conclusions on what is hemp vs. marijuana.
While there is plenty of debate around what is hemp and what is non-hemp cannabis, differences are defined more by history and use than by botany.
With Privilege Comes Responsibility
As early entrants and investment leaders, we are driven by a passion and belief that purposeful cannabis investment will play a significant role Beyond Impact.
The MAZAKALI GreenPaper® has gained authority through knowledge on deep trends in the industry that matter to investors and operators alike.
MAZAKALI LLC (“MAZAKALI”) is an investment adviser registered with the state of California and is not a registered broker dealer. MAZAKALI’s principal, Sumit Mehta is an investment adviser representative of MAZAKALI and is also separately registered as an associated person of Growth Capital Services, Inc., a licensed broker-dealer and member of FINRA/SIPC (“GCS”), office of supervisory jurisdiction located at 582 Market Street, Suite 300, San Francisco, CA 94104. GCS and Mazakali are separate entities, and only certain securities brokered by Sumit Mehta are offered and sold through GCS. You can find more information about GCS and Mr. Mehta here and through FINRA Broker check.
Investment advisory services are provided exclusively from MAZAKALI’s San Francisco office. Registration as an investment adviser does not imply any particular skill or training. Any securities offered by Mr. Mehta are offered through GCS pursuant to an exemption from the registration requirements of the Securities Act of 1933, as amended (“Securities Act”), and such private placements are not subject to the disclosure requirements that apply to registered securities under the Securities Act. Unregistered securities, and investments in the cannabis industry in particular, are speculative, and considered by regulators to involve a high degree of risk. Any descriptions of securities or companies on the MAZAKALI website do not constitute a recommendation, solicitation, or investment advice by MAZAKALI, GCS or its registered representatives, including Mr. Mehta.
Any statements other than those of historical fact are estimates only, and not an indication of any future investment performance. Past performance is not a guarantee of future results. Moreover, none of MAZAKALI, GCS, or any of its registered representatives makes any representation, warranty or guaranty of any kind, express or implied, as to the accuracy, completeness or reasonableness of the information contained on the MAZAKALI website, or of any other written or oral communication transmitted or made available to any interested party.
Offerings and services may only be available to certain investor types, classes and/or groups, depending upon the type of offering, various regulatory requirements, and/or the preferences of the issuer and their advisers; including, but not limited to, limiting deal access or investment capability to accredited investors. In the most sensible investment strategy, alternative investments should only be part of your overall investment portfolio. Potential investors are advised to consult with their tax, legal and financial advisors before making any investment.